How bad is my prostate cancer??? We’ve all asked ourselves that! Today there are tests to predict its gravity early in the diagnosis and after surgery.
How do these tests work?
… what’s inside the ‘black box’ that makes it an accurate crystal ball?
… and are all tests born equal?
… the test manufacturers won’t say BUT one doc who will is Dr. Todd Morgan – he’s looked inside all of them.
Dr. Morgan is Chief Urologist at the University of Michigan and leads the MUSIC* program.
He will discuss:
the difference between inherited and somatic testing
who should undergo genomic testing
how tests are able to predict
his upcoming randomized trial comparing the leading genomic tests, Decipher, Prolaris, and Oncotype DX
… and more including your questions
* Michigan Urological Surgery and Improvement Collaborative
Dr. Morgan has served on several national guideline committees, including the American Urological Association’s Advanced Prostate Cancer Guidelines, the National Comprehensive Cancer Network’s Prostate Cancer Early Detection Guidelines, the American Society for Clinical Oncology’s Localized Prostate Cancer Guidelines, and the ASCO Molecular Markers for Prostate Cancer Guidelines.
Watch here:
Special thanks to Bayer, Pfizer, Myovant Sciences, Foundation Medicine, Myriad Genetics, Janssen – Johnson & Johnson, Telix, and Blue Earth Diagnostics for sponsoring this webinar.
For information on our peer-led video chat PROSTATE CANCER VIRTUAL SUPPORT GROUPS, click here.
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.